SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-032458
Filing Date
2024-03-08
Accepted
2024-03-08 16:49:31
Documents
18
Period of Report
2024-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248308d1_8k.htm   iXBRL 8-K 41648
2 EXHIBIT 10.1 tm248308d1_ex10-1.htm EX-10.1 63882
3 EXHIBIT 10.2 tm248308d1_ex10-2.htm EX-10.2 11912
7 GRAPHIC tm248308d1_ex10-1img001.jpg GRAPHIC 6127
8 GRAPHIC tm248308d1_ex10-2img001.jpg GRAPHIC 5824
  Complete submission text file 0001104659-24-032458.txt   334854

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20240308.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20240308_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20240308_pre.xml EX-101.PRE 22357
19 EXTRACTED XBRL INSTANCE DOCUMENT tm248308d1_8k_htm.xml XML 3631
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 24735195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)